Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Endocrinol. 2014 Jun;221(3):R163–R176. doi: 10.1530/JOE-14-0039

Figure 9.

Figure 9

PA spine BMD increased in women receiving risedronate (solid line) over a 12-month period compared with those receiving placebo (dotted line) (P< 0.0001). Z-scores are shown. (Reprinted with permission from the J Clin Endocrinol Metab. 2011 July; 96(7): 2081–2088. Copyright © 2011 The Endocrine Society. All rights reserved).